Vergleich

Rhodopsin

Hersteller GENWAY
Kategorie
Typ Antibody
Specific against other
Applikationen IHC
Menge 0.05 ml
ArtNr 18-461-10321
eClass 6.1 32160702
eClass 9.0 32160702
Lieferbar
Genway ID:
GWB-8C2EED
Immunogen:
2nd extracellular domain of human. Synthetic peptide - KLH conjugated.
Uses: IHC (1 - 3 ug/ml) (Optimal dilution to be determined by the researcher)
Function:
Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein opsin covalently linked to cis-retinal. Biophysicochemical Properties:
Subcellular Location:
Membrane; multi-pass membrane protein.
Tissue Specificity:
Rod shaped photoreceptor cells which mediates vision in dim light.
Ptm:
Phosphorylated on some or all of the serine and threonine residues present in the C-terminal region.
Disease:
Defects in RHO are a cause of autosomal dominant retinitis pigmentosa (ADRP) [MIM:268000]. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses they lose their far peripheral visual field and eventually central vision as well.
Disease:
Defects in RHO are a cause of autosomal recessive retinitis pigmentosa (ARRP) [MIM:268000].
Disease:
Defects in RHO are a cause of rhodopsin related congenital stationary night blindness (CSNB) [MIM:163500].
Similarity:
Belongs to the G-protein coupled receptor 1 family. Opsin subfamily [view classification]. Summary: Retinitis pigmentosa is an inherited progressive disease which is a major cause of blindness in western communities. It can be inherited as an autosomal dominant autosomal recessive or X-linked recessive disorder. In the autosomal dominant form which comprises about 25% of total cases approximately 30% of families have mutations in the gene encoding the rod photoreceptor-specific protein rhodopsin. This is the transmembrane protein which when photoexcited initiates the visual transduction cascade. Defects in this gene are also one of the causes of congenital stationary night blindness. [1] Neidhardt J. Barthelmes D. Farahmand F. Fleischhauer J. C. and Berger W. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes[2] Zhang X. L. Liu M. Meng X. H. Fu W. L. Yin Z. Q. Huang J. F. and Zhang X. Mutational analysis of the rhodopsin gene in Chinese ADRP families by conformation sensitive gel electrophoresis[3] Galy A. Roux M. J. Sahel J. A. Leveillard T. and Giangrande A. et al. Rhodopsin maturation defects induce photoreceptor death by apoptosis: a fly model for RhodopsinPro23His human retinitis pigmentosa[4] Mendes H. F. van der Spuy J. Chapple J. P. and Cheetham M. E. et al. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy[5] Yuan L. Kawada M. Havlioglu N. Tang H. and Wu J. Y. et al. Mutations in PRPF31 inhibit pre-mRNA splicing of rhodopsin gene and cause apoptosis of retinal cells[6] Nathans J. Hogness D. S. Isolation and nucleotide sequence of the gene encoding human rhodopsin. [7] Suwa M. Sato T. Okouchi I. Arita M. Futami K. Matsumoto S. Tsutsumi S. Aburatani H. Asai K. Akiyama Y. et al. Genome-wide discovery and analysis of human seven transmembrane helix receptor genes. [8] Bennett J. Beller B. Sun D. Kariko K. Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases. [9] Al-Maghtheh M. Gregory C. Inglehearn C. Hardcastle A. Bhattacharya S. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. [10] Dryja T. P. McGee T. L. Reichei E. Hahn L. B. Cowley G. S. Yandell D. W. Sandberg M. A. Berson E. L. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.05 ml
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 13.06.2024 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen